Eribulin Mesylate, (HALAVEN) works for treating metastatic or advanced breast cancer  that has spread to other parts of the body and who have already received other types of anticancer medicines after the cancer has spread. Eribulin Mesylate is a doctor prescription (Eribulin Mesylate) medicine.

Eisai Co. Ltd. of India mfg HALAVEN.

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Suggestion:

Genuine medicine is important for treatment. So, always try to source genuine medicines from authentic sources and check the quality of medicines.

Side Effect:

The most common side effects of Eribulin Mesylate are:

Low blood cell counts, low calcium or potassium levels, nausea, constipation, hair loss or feeling tired or weak. Tell your doctor or pharmacist right away if any of these side effects persist or worsen.

Remember that your doctor has prescribed this medication because your doctor has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.

Tell your doctor right away if you have any serious side effects, including: chest pain, severe dizziness, fast or pounding heartbeats, numbness, tingling, or burning pain in your hands or feet pain or burning when you urinate, low calcium level–muscle spasms or contractions, numbness or tingly feeling (around your mouth, or in your fingers and toes) low potassium level–leg cramps, constipation, irregular heartbeats, fluttering in your chest, increased thirst or urination, numbness or tingling, muscle weakness or limp feeling or low blood cell counts–fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath.

Any advice on the use of the drug is for reference only. Please consult with doctor for medical advice.

This is not a complete list of possible side effects. Contact your doctor or pharmacist if you have any other side effects not listed above.